Careful with your predictions, you're getting ahead of where 2-73 ACTUALLY is. This is what happen last November; we got ahead of ourselves in terms of expectations and that didn't go well. The PRELIMINARY data looks great, but it's just that, PRELIMINARY. AVXL needs pivotal trial results for 2-73 before any claims such as yours can be solidified. I'm hopeful that the 12 week data is good and the results assist in designing an efficient phase 2/3.